T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Omnicom Group
OMC
$24.2B
| $68.8M | 0.01% |
843,751
+331,613
| +65% | +$24.6M |
|
577
Murphy USA
MUSA
$10.4B
| $68.2M | 0.01% |
244,102
+7,902
| +3% | +$2.29M |
|
578
Acadia Pharmaceuticals
ACAD
$4.89B
| $68.1M | 0.01% |
4,279,254
-612,094
| -13% | -$9.57M |
|
579
Cooper Companies
COO
$14.9B
| $68.1M | 0.01% |
823,632
-947,168
| -53% | -$69.9M |
|
580
Inspire Medical Systems
INSP
$1.68B
| $67.7M | 0.01% |
268,747
+4,081
| +2% | +$870K |
|
581
Post Holdings
POST
$3.65B
| $67.4M | 0.01% |
746,499
+20,292
| +3% | +$1.81M |
|
582
Archer Daniels Midland
ADM
$38.6B
| $67.3M | 0.01% |
725,068
-12,282
| -2% | -$1.13M |
|
583
Intellia Therapeutics
NTLA
$1.66B
| $67.3M | 0.01% |
1,929,355
+192,095
| +11% | +$9.13M |
|
584
Relay Therapeutics
RLAY
$4.37B
| $67.1M | 0.01% |
4,493,004
-68,359
| -1% | -$1.31M |
|
585
Churchill Downs
CHDN
$6.2B
| $66.9M | 0.01% |
632,876
-3,224
| -0.5% | -$340K |
|
586
AMN Healthcare
AMN
$1.34B
| $66.8M | 0.01% |
649,544
+1,652
| +0.3% | +$190K |
|
|
RAPT
587
DELISTED
RAPT Therapeutics
RAPT
| $66.6M | 0.01% |
420,611
+35,643
| +9% | +$5.7M |
|
588
Keysight
KEYS
$60.5B
| $66.2M | 0.01% |
387,130
-777
| -0.2% | -$132K |
|
589
Shoals Technologies Group
SHLS
$1.37B
| $66.2M | 0.01% |
2,682,083
-448,604
| -14% | -$10.8M |
|
590
Crocs
CROX
$6.36B
| $65.6M | 0.01% |
604,925
-1,174
| -0.2% | -$104K |
|
591
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
| $65.6M | 0.01% |
1,086,977
+7,700
| +0.7% | +$458K |
|
592
Globus Medical
GMED
$11.5B
| $64.9M | 0.01% |
873,901
+2,143
| +0.2% | +$146K |
|
593
Comfort Systems
FIX
$60.8B
| $64.3M | 0.01% |
558,627
-43,081
| -7% | -$5.01M |
|
|
MRTX
594
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $64.2M | 0.01% |
1,416,728
+273,973
| +24% | +$17.7M |
|
595
Phillips 66
PSX
$92.8B
| $64.1M | 0.01% |
616,330
-6,469
| -1% | -$662K |
|
596
Texas Roadhouse
TXRH
$13.6B
| $63.8M | 0.01% |
701,687
+24,371
| +4% | +$2.34M |
|
597
Sweetgreen
SG
$721M
| $63.7M | 0.01% |
7,436,584
-5,579,723
| -43% | -$81.3M |
|
598
KKR & Co
KKR
$103B
| $63.7M | 0.01% |
1,371,665
-169,264
| -11% | -$8.25M |
|
599
Scholar Rock
SRRK
$6.46B
| $63.7M | 0.01% |
7,035,020
+126,878
| +2% | +$1.02M |
|
600
DuPont de Nemours
DD
$19.5B
| $63.4M | 0.01% |
736,334
-13,768
| -2% | -$1.1M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.